165 related articles for article (PubMed ID: 33655544)
1. Comparative neurological safety of fluoroquinolones versus therapeutic alternatives.
Ellis DE; Hubbard RA; Willis AW; Zuppa AF; Zaoutis TE; Hennessy S
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):797-805. PubMed ID: 33655544
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic.
Ellis DE; Hubbard RA; Willis AW; Zuppa AF; Zaoutis TE; Hennessy S
Diabetes Res Clin Pract; 2022 Mar; 185():109225. PubMed ID: 35122901
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of disability in patients exposed to fluoroquinolones.
Wilcox MA; Villasis-Keever A; Sena AG; Knoll C; Fife D
BMC Pharmacol Toxicol; 2020 Jun; 21(1):40. PubMed ID: 32493505
[TBL] [Abstract][Full Text] [Related]
4. Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.
Ellis DE; Hubbard RA; Willis AW; Zuppa AF; Zaoutis TE; Hennessy S
Pharmacoepidemiol Drug Saf; 2022 Apr; 31(4):393-403. PubMed ID: 34881470
[TBL] [Abstract][Full Text] [Related]
5. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
[TBL] [Abstract][Full Text] [Related]
6. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.
Newton ER; Akerman AW; Strassle PD; Kibbe MR
JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study.
Daneman N; Chateau D; Dahl M; Zhang J; Fisher A; Sketris IS; Quail J; Marra F; Ernst P; Bugden S;
Clin Microbiol Infect; 2020 May; 26(5):613-618. PubMed ID: 31655215
[TBL] [Abstract][Full Text] [Related]
8. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Gopalakrishnan C; Bykov K; Fischer MA; Connolly JG; Gagne JJ; Fralick M
JAMA Intern Med; 2020 Dec; 180(12):1596-1605. PubMed ID: 32897307
[TBL] [Abstract][Full Text] [Related]
9. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
Langner JL; Chiang KF; Stafford RS
Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
[TBL] [Abstract][Full Text] [Related]
10. Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
Morales DR; Slattery J; Pinheiro L; Kurz X; Hedenmalm K
Clin Drug Investig; 2018 Oct; 38(10):927-933. PubMed ID: 30143952
[TBL] [Abstract][Full Text] [Related]
11. Oral Fluoroquinolones and the Risk of Uveitis.
Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
[TBL] [Abstract][Full Text] [Related]
12. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Wang J; Gagne JJ; Kattinakere-Sreedhara S; Fischer MA; Bykov K
BMJ; 2022 Oct; 379():e069931. PubMed ID: 36195324
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
Assimon MM; Pun PH; Wang LC; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
JAMA Cardiol; 2022 Jan; 7(1):75-83. PubMed ID: 34668928
[TBL] [Abstract][Full Text] [Related]
14. High risk of Clostridium difficile infection among spinal cord injured patients after the use of antibiotics commonly used to treat urinary tract infections.
Liu B; Reid J; Silverman M; Welk B
Neurourol Urodyn; 2020 Nov; 39(8):2401-2408. PubMed ID: 32902908
[TBL] [Abstract][Full Text] [Related]
15. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
[TBL] [Abstract][Full Text] [Related]
16. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
Saad S; Mina N; Lee C; Afra K
BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
[TBL] [Abstract][Full Text] [Related]
17. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
[TBL] [Abstract][Full Text] [Related]
18. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
[TBL] [Abstract][Full Text] [Related]
19. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
[TBL] [Abstract][Full Text] [Related]
20. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
